Immunic, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $84.4M | $86.6M |
| Jun 2017 | — | $73.3M | $76.2M |
| Sep 2017 | — | $62.1M | $66.4M |
| Dec 2017 | — | $-13.3M | $56.9M |
| Mar 2018 | — | $-15.6M | $43.6M |
| Jun 2018 | — | $-19.0M | $31.1M |
| Sep 2018 | — | $-20.8M | $17.8M |
| Dec 2018 | — | $-25.7M | $13.1M |
| Mar 2019 | — | $-9.8M | $7.6M |
| Jun 2019 | — | $69.4M | $36.1M |
| Sep 2019 | — | $60.5M | $30.5M |
| Dec 2019 | — | $58.4M | $29.4M |
| Mar 2020 | — | $50.5M | $18.6M |
| Jun 2020 | — | $78.7M | $48.6M |
| Sep 2020 | — | $162.9M | $133.2M |
| Dec 2020 | — | $158.8M | $127.5M |
| Mar 2021 | — | $137.4M | $114.8M |
| Jun 2021 | — | $120.7M | $87.2M |
| Sep 2021 | — | $145.5M | $110.4M |
| Dec 2021 | — | $127.1M | $86.9M |
| Mar 2022 | — | $138.0M | $95.7M |
| Jun 2022 | — | $127.8M | $88.1M |
| Sep 2022 | — | $108.8M | $72.8M |
| Dec 2022 | — | $113.7M | $106.7M |
| Mar 2023 | — | $91.2M | $92.8M |
| Jun 2023 | — | $69.3M | $77.3M |
| Sep 2023 | — | $48.4M | $59.7M |
| Dec 2023 | — | $28.9M | $46.7M |
| Mar 2024 | — | $83.6M | $97.3M |
| Jun 2024 | — | $63.6M | $79.7M |
| Sep 2024 | — | $41.2M | $59.1M |
| Dec 2024 | — | $18.4M | $35.7M |
| Mar 2025 | — | $-5.3M | $14.3M |
| Jun 2025 | — | $33.9M | $55.3M |
| Sep 2025 | — | $10.5M | $35.1M |
| Dec 2025 | — | $-6.7M | $15.5M |
| Mar 2026 | — | $151.2M | $186.6M |
| Jun 2026 | — | $127.6M | $155.1M |